Financhill
Sell
33

ATLX Quote, Financials, Valuation and Earnings

Last price:
$6.30
Seasonality move :
135.45%
Day range:
$6.30 - $6.56
52-week range:
$6.25 - $34.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.17x
Volume:
70.4K
Avg. volume:
107.6K
1-year change:
-75.5%
Market cap:
$97M
Revenue:
--
EPS (TTM):
-$4.17
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $15.4K $23.5K $10.2K -- --
Revenue Growth (YoY) -21.93% 52.32% -56.36% -- --
 
Cost of Revenues $182.2K $129.9K $245.8K -- --
Gross Profit -$166.8K -$106.5K -$235.6K -- --
Gross Profit Margin -1083.45% -454.22% -2302.37% -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.1M $1.2M $3.3M $5.3M $25.4M
Other Inc / (Exp) -$66.8K $162.8K -$255.8K -$254.5K -$368.8K
Operating Expenses $1.1M $1.2M $3.3M $5.9M $42.1M
Operating Income -$1.3M -$1.3M -$3.5M -$5.9M -$42.1M
 
Net Interest Expenses $754.7K $427.3K $253.6K -- --
EBT. Incl. Unusual Items -$2.1M -$1.5M -$4M -$6.1M -$42M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$2.1M -$1.5M -$4M -$6.1M -$42M
 
Minority Interest in Earnings $223.8K $404.4K $1.3M $1.1M $1.2M
Net Income to Common Excl Extra Items -$1.9M -$1.1M -$2.8M -$4.9M -$40.8M
 
Basic EPS (Cont. Ops) -$1.74 -$0.67 -$0.75 -$1.07 -$4.37
Diluted EPS (Cont. Ops) -$1.74 -$0.67 -$0.75 -$1.07 -$4.37
Weighted Average Basic Share $1.1M $1.7M $3.7M $4.6M $9.3M
Weighted Average Diluted Share $1.1M $1.7M $3.7M $4.6M $9.3M
 
EBITDA -$1.3M -$1.1M -$3.7M -$5.8M -$42.1M
EBIT -$1.3M -$1.1M -$3.8M -$5.9M -$42.1M
 
Revenue (Reported) $15.4K $23.5K $10.2K -- --
Operating Income (Reported) -$1.3M -$1.3M -$3.5M -$5.9M -$42.1M
Operating Income (Adjusted) -$1.3M -$1.1M -$3.8M -$5.9M -$42.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $10.7K $3K $3.3K -- $169.6K
Revenue Growth (YoY) 63.23% -72.08% 10.62% -- --
 
Cost of Revenues $26.9K $27.4K $27.5K -- $100.1K
Gross Profit -$16.2K -$24.4K -$24.2K -- $69.5K
Gross Profit Margin -151.76% -817.63% -734.11% -- 40.97%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $303.4K $707.3K $1.1M $5.5M $10.3M
Other Inc / (Exp) $220 -- $1.9K -$295.7K $81.2K
Operating Expenses $303.4K $707.3K $1.2M $11.4M $10.3M
Operating Income -$319.6K -$731.7K -$1.3M -$11.4M -$10.3M
 
Net Interest Expenses $53.2K $88.9K -- -- --
EBT. Incl. Unusual Items -$372.6K -$820.6K -$1.3M -$11.7M -$9.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $4.3K
Net Income to Company -$372.6K -$820.6K -$1.3M -$11.7M -$9.7M
 
Minority Interest in Earnings $101.4K $201.5K $241.8K $458.9K $688.9K
Net Income to Common Excl Extra Items -$271.2K -$619.1K -$1M -$11.3M -$9M
 
Basic EPS (Cont. Ops) -$0.18 -$0.16 -$0.22 -$1.24 -$0.60
Diluted EPS (Cont. Ops) -$0.18 -$0.16 -$0.22 -$1.24 -$0.60
Weighted Average Basic Share $1.5M $3.9M $4.6M $9.1M $15M
Weighted Average Diluted Share $1.5M $3.9M $4.6M $9.1M $15M
 
EBITDA -$315.2K -$727.2K -$1.3M -$11.4M -$10.2M
EBIT -$319.4K -$731.7K -$1.3M -$11.4M -$10.3M
 
Revenue (Reported) $10.7K $3K $3.3K -- $169.6K
Operating Income (Reported) -$319.6K -$731.7K -$1.3M -$11.4M -$10.3M
Operating Income (Adjusted) -$319.4K -$731.7K -$1.3M -$11.4M -$10.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $21.1K $10.3K $7.3K -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $144.2K $117.6K $235.1K -- --
Gross Profit -$123.1K -$107.3K -$227.8K $57.6K $245.1K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.1M $2.9M $3.6M $16.2M $41.6M
Other Inc / (Exp) -$74.6K $13.6K -$27.3K -$413.2K $165.9K
Operating Expenses $1.1M $2.9M $3.8M $28.2M $49.9M
Operating Income -$1.2M -$3M -$4M -$28.2M -$49.7M
 
Net Interest Expenses $578.5K $296.4K $1.7K -- --
EBT. Incl. Unusual Items -$1.9M -$3.3M -$4M -$28.5M -$49.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$1.9M -$3.3M -$4M -$28.5M -$49.2M
 
Minority Interest in Earnings $359.9K $1.1M $1M $1.7M $1.7M
Net Income to Common Excl Extra Items -$1.5M -$2.2M -$3M -$26.9M -$47.6M
 
Basic EPS (Cont. Ops) -$0.97 -$0.54 -$0.68 -$3.39 -$4.17
Diluted EPS (Cont. Ops) -$0.97 -$0.65 -$0.68 -$3.39 -$4.17
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$1.3M -$2.9M -$4M -$28.1M -$49.5M
EBIT -$1.3M -$3M -$4M -$28.2M -$49.7M
 
Revenue (Reported) $21.1K $10.3K $7.3K -- --
Operating Income (Reported) -$1.2M -$3M -$4M -$28.2M -$49.7M
Operating Income (Adjusted) -$1.3M -$3M -$4M -$28.2M -$49.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $22.3K $9.1K $6.2K -- $539.1K
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $86.8K $74.5K $63.7K -- $293.9K
Gross Profit -$64.6K -$65.4K -$57.6K -- $245.1K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $857.5K $2.6M $2.9M $13.8M $30M
Other Inc / (Exp) -$75.3K -$224.6K $3.9K -$154.8K $379.9K
Operating Expenses $857.5K $2.6M $3.1M $25.4M $33.2M
Operating Income -$922.1K -$2.6M -$3.1M -$25.4M -$33M
 
Net Interest Expenses $382.9K $252K -- -- $702K
EBT. Incl. Unusual Items -$1.4M -$3.1M -$3.1M -$25.6M -$32.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $10.5K
Net Income to Company -$1.4M -$3.1M -$3.1M -$25.6M -$32.9M
 
Minority Interest in Earnings $270.7K $940.3K $687.3K $1.2M $1.7M
Net Income to Common Excl Extra Items -$1.1M -$2.2M -$2.4M -$24.4M -$31.2M
 
Basic EPS (Cont. Ops) -$0.77 -$0.64 -$0.54 -$2.85 -$2.56
Diluted EPS (Cont. Ops) -$0.77 -$0.64 -$0.54 -$2.85 -$2.56
Weighted Average Basic Share $4.4M $10.3M $13.3M $24.8M $38.8M
Weighted Average Diluted Share $4.4M $10.3M $13.3M $24.8M $38.8M
 
EBITDA -$968K -$2.8M -$3.1M -$25.4M -$32.9M
EBIT -$997.4K -$2.9M -$3.1M -$25.4M -$33M
 
Revenue (Reported) $22.3K $9.1K $6.2K -- $539.1K
Operating Income (Reported) -$922.1K -$2.6M -$3.1M -$25.4M -$33M
Operating Income (Adjusted) -$997.4K -$2.9M -$3.1M -$25.4M -$33M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $151.1K $253.6K $22.8K $280.4K $29.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- $20.1K $1.4K -- --
Inventory $15.1K $11.7K -- -- --
Prepaid Expenses $4.8K $2K $17.3K -- --
Other Current Assets -- -- -- $47.1K $113.9K
Total Current Assets $193.8K $305.2K $57.9K $327.5K $29.7M
 
Property Plant And Equipment $172.8K $496.7K $53.9K $4.7M $13.8M
Long-Term Investments $150K $150K $150K -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- $1.3M -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $1M $951.9K $1.6M $5.1M $43.6M
 
Accounts Payable $153.7K $327.7K $310.1K $1.1M $3.6M
Accrued Expenses $496.5K $324.4K $5.6K -- --
Current Portion Of Long-Term Debt $1.5M $1.7M -- -- $67K
Current Portion Of Capital Lease Obligations -- -- -- -- $127.5K
Other Current Liabilities -- -- -- $57.8K $1M
Total Current Liabilities $2.2M $2.3M $998.4K $3.5M $5.9M
 
Long-Term Debt -- -- -- -- $9.7M
Capital Leases -- -- -- -- --
Total Liabilities $2.3M $2.4M $1.1M $3.6M $35.9M
 
Common Stock $1.1M $2M $4.4K $5.3K $12.8K
Other Common Equity Adj -$581K -$775.1K -$712.8K -$6.6K -$138.8K
Common Equity -$2.8M -$3.5M -$1.1M $1.7M $7.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.4M $2M $1.6M -$212.2K $427.3K
Total Equity -$1.3M -$1.5M $456.9K $1.5M $7.7M
 
Total Liabilities and Equity $1M $951.9K $1.6M $5.1M $43.6M
Cash and Short Terms $151.1K $253.6K $22.8K $280.4K $29.5M
Total Debt $1.5M $1.7M -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $284K $18.1K $418.3K $22.9M $22.1M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $18.2K $380 $250 -- $151.1K
Inventory $10.8K $11.2K -- -- $545.3K
Prepaid Expenses $950 $17.9K $26K $68.8K --
Other Current Assets -- -- -- -- $105.4K
Total Current Assets $330.3K $64.5K $461.6K $22.9M $22.9M
 
Property Plant And Equipment $98.5K $64.3K $118K $285.5K $37.1M
Long-Term Investments $150K $150K $150K -- --
Goodwill -- -- -- -- --
Other Intangibles $375.6K $1.3M $4.8M $5.9M $388.1K
Other Long-Term Assets -- -- -- -- $122.7K
Total Assets $954.3K $1.6M $5.6M $29.1M $60.5M
 
Accounts Payable $88.4K $291.3K $441.7K $2.2M $5.8M
Accrued Expenses $587.7K $3K -- -- --
Current Portion Of Long-Term Debt $1.9M $97.8K $14.8K -- $245.8K
Current Portion Of Capital Lease Obligations -- -- -- -- $165K
Other Current Liabilities -- -- -- -- $287.4K
Total Current Liabilities $2.6M $1.1M $2.9M $2.6M $6.5M
 
Long-Term Debt -- -- -- -- $9.8M
Capital Leases -- -- -- -- --
Total Liabilities $2.7M $1.2M $3M $22.7M $36.7M
 
Common Stock $1.5M $3.1M $3.7M $10.7K $15.3K
Other Common Equity Adj -$816.1K -$749.4K -$688K -$1.1M -$157K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.9M $1.5M $1.4M -$124.3K $527.5K
Total Equity -$1.7M $420.8K $2.6M $6.4M $23.8M
 
Total Liabilities and Equity $954.3K $1.6M $5.6M $29.1M $60.5M
Cash and Short Terms $284K $18.1K $418.3K $22.9M $22.1M
Total Debt $1.9M $97.8K $14.8K -- $10M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$2.1M -$1.5M -$4M -$6.1M -$42M
Depreciation & Amoritzation $63.5K $47.8K $37.3K $14.7K $24.9K
Stock-Based Compensation $175.4K $168K $1.7M $2.5M $15.5M
Change in Accounts Receivable $490 -$30.4K $17.9K -$3.8K -$50.6K
Change in Inventories -- -- -- -- --
Cash From Operations -$791.1K -$996.8K -$1.1M -$3.2M -$6M
 
Capital Expenditures $700 $13.6K $961.4K -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$680 -$13.6K -$961.4K -$1M -$8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $478.9K $26.2K $149.5K -- $10M
Long-Term Debt Repaid -$318.5K -$16.9K -$235.3K -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $657.5K $775.3K $801.2K $600K --
Cash From Financing $941.9K $1.1M $1.8M $4.4M $43.2M
 
Beginning Cash (CF) $2.4K $151.1K $253.6K $22.8K $280.4K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $150.1K $94.1K -$273.1K $204K $29.2M
Ending Cash (CF) $151.1K $253.6K $22.8K $280.4K $29.5M
 
Levered Free Cash Flow -$791.7K -$1M -$2.1M -$4.2M -$13.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$372.6K -$820.6K -$1.3M -$11.7M -$9.7M
Depreciation & Amoritzation $4.3K $4.5K -$44K $22K $70.8K
Stock-Based Compensation $25.7K $373.1K $386.3K $3.7M $6.3M
Change in Accounts Receivable $1.5K $550 $660 $9K $7K
Change in Inventories -- -- -- -- -$394.6K
Cash From Operations -$241.2K -$1.1M $1.1M -$8.5M -$2.9M
 
Capital Expenditures -$400 -$685.8K $2.3M -$1.2M $6.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing $410 $685.8K -$2.3M $1.2M -$6.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -$279.7K -- -- --
Long-Term Debt Repaid $3.4K $270K -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $125K $224.5K $50K $150K -$449.5K
Cash From Financing $228.4K $364.7K $1.3M $10.1M $151.3K
 
Beginning Cash (CF) $327.4K $62.1K $54.2K $20.2M $32.3M
Foreign Exchange Rate Adjustment -$31K $9.6K $4.3K -$144.6K -$659.6K
Additions / Reductions -$12.4K -$53.5K $359.8K $2.8M -$9.6M
Ending Cash (CF) $284K $18.1K $418.3K $22.9M $22.1M
 
Levered Free Cash Flow -$240.8K -$417.1K -$1.3M -$7.3M -$9.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$1.9M -$3.3M -$4M -$28.5M -$49.2M
Depreciation & Amoritzation $49.2K $46.5K -$7.5K $61.5K $130.6K
Stock-Based Compensation $115.4K $1.5M $1.2M $9.1M $25.9M
Change in Accounts Receivable -$30.6K $19.4K -$700 $1.1K -$9.2K
Change in Inventories -- -- -- -- --
Cash From Operations -$785.4K -$1.5M -$158.7K -$339.8K -$22.7M
 
Capital Expenditures $13.3K $273.1K $3.3M -$781.5K $30.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$13.3K -$273.1K -$3.3M $781.5K -$30.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $125K -- -- --
Long-Term Debt Repaid -$133.7K -$214.9K -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $787.5K $706.5K $920K $325K --
Cash From Financing $984K $1.5M $3.7M $22M $52.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $185.3K -$261K $319.4K $22.5M -$872.1K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$798.7K -$1.8M -$3.4M $441.7K -$53.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$1.4M -$3.1M -$3.1M -$25.6M -$32.9M
Depreciation & Amoritzation $29.4K $28.1K -$16.7K $30.1K $135.8K
Stock-Based Compensation $79.9K $1.4M $1M $7.7M $18.1M
Change in Accounts Receivable -$30.6K $19.2K $570 $5.5K $46.8K
Change in Inventories -- -- -- -- -$545.3K
Cash From Operations -$702K -$1.2M -$258.3K $2.6M -$14.2M
 
Capital Expenditures $12.7K $272.2K $2.6M $772K $23.6M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$12.7K -$272.2K -$2.6M -$772K -$23.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $26.2K $125K -- -- --
Long-Term Debt Repaid -$37.3K -$235.3K -- -- -$309.2K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $525K $456.2K $575K $300K --
Cash From Financing $833.9K $1.2M $3.2M $20.8M $30.3M
 
Beginning Cash (CF) $671.6K $577.9K $131.2K $25.4M $79.3M
Foreign Exchange Rate Adjustment $13.7K $420 $38.9K -$38.7K -$12.8K
Additions / Reductions $119.2K -$235.9K $356.6K $22.6M -$7.5M
Ending Cash (CF) $804.5K $342.5K $526.7K $48M $71.9M
 
Levered Free Cash Flow -$714.7K -$1.5M -$2.8M $1.8M -$37.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock